Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer

  Free Subscription


09.09.2019

1 Adv Clin Exp Med
1 Am J Surg Pathol
1 Anal Chem
1 Anim Cells Syst (Seoul)
4 Asian Pac J Cancer Prev
1 Biores Open Access
3 BMJ Open
1 Cancer Imaging
1 Cancer Res Treat
2 Carbohydr Polym
1 Cell Death Dis
1 Ceska Gynekol
1 Cytopathology
1 Eur J Obstet Gynecol Reprod Biol
1 Eur Radiol
1 Eur Rev Med Pharmacol Sci
1 Front Oncol
3 Gynecol Oncol
2 In Vivo
1 Infection
1 Int J Cancer
1 Int J Gynaecol Obstet
3 Int J Gynecol Cancer
1 Int J Mol Sci
1 J Clin Microbiol
1 J Exp Clin Cancer Res
1 J Gene Med
1 J Glob Oncol
1 J Mass Spectrom
1 J Obstet Gynaecol
1 J Womens Health (Larchmt)
1 Medicines (Basel)
1 Mol Genet Genomic Med
1 Niger J Clin Pract
1 Oncol Rep
1 Pan Afr Med J
1 PLoS One
1 Sci Rep
1 Zhongguo Yi Xue Ke Xue Yuan Xue Bao
1 Zhonghua Fu Chan Ke Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Adv Clin Exp Med

  1. SINDHWANI A, Muthusammy S, Bhatia A
    Vitamin C may exert variable effects on viability and proliferation of HeLa cells exhibiting high and low chromosomal instability.
    Adv Clin Exp Med. 2019;28:19-24.
    PubMed     Text format     Abstract available


    Am J Surg Pathol

  2. PORS J, Cheng A, Leo JM, Kinloch MA, et al
    A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
    Am J Surg Pathol. 2018 Aug 24. doi: 10.1097/PAS.0000000000001142.
    PubMed     Text format     Abstract available


    Anal Chem

  3. ALJAKOUCH K, Hilal Z, Daho I, Schuler M, et al
    Fast Non-invasive Diagnosis of Cervical Cancer by Coherent anti-Stokes Raman Scattering.
    Anal Chem. 2019 Sep 4. doi: 10.1021/acs.analchem.9b03395.
    PubMed     Text format     Abstract available


    Anim Cells Syst (Seoul)

  4. KIM MY, Kim YS, Kim M, Choi MY, et al
    Metformin inhibits cervical cancer cell proliferation via decreased AMPK O-GlcNAcylation.
    Anim Cells Syst (Seoul). 2019;23:302-309.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  5. DOS SANTOS AV, dos Santos GT, Brackmann RL, Prolla JC, et al
    Follow-Up of Women with Cervical Cytological Abnormalities: Progression and Regression Events
    Asian Pac J Cancer Prev. 2019;20:1019-1024.
    PubMed     Text format     Abstract available

  6. ACUCENA VIEIRA ALVES S, Schiaveto de Souza A, Weller M, Pires Batiston A, et al
    Differential Impact of Education Level, Occupation and Marital Status on Performance of the Papanicolaou Test among Women from Various Regions in Brazil
    Asian Pac J Cancer Prev. 2019;20:1037-1044.
    PubMed     Text format     Abstract available

  7. WUDTISAN J, Tantipalakorn C, Charoenkwan K, Sreshthaputra RA, et al
    Factors Associated with Development of High-Grade Squamous Intraepithelial Lesions of the Uterine Cervix in Women Younger than 30 Years
    Asian Pac J Cancer Prev. 2019;20:1031-1036.
    PubMed     Text format     Abstract available

  8. LI N, Zhang FB, Li BJ, Wang RT, et al
    Combination of Preoperative D-Dimer and Platelet Distribution width Predicts Postoperative Deep Venous Thrombosis in Patients with Cervical Carcinoma
    Asian Pac J Cancer Prev. 2019;20:1025-1029.
    PubMed     Text format     Abstract available


    Biores Open Access

  9. MBURU A, Itsura P, Mabeya H, Kaaria A, et al
    Knowledge of Cervical Cancer and Acceptability of Prevention Strategies Among Human Papillomavirus-Vaccinated and Human Papillomavirus-Unvaccinated Adolescent Women in Eldoret, Kenya.
    Biores Open Access. 2019;8:139-145.
    PubMed     Text format     Abstract available


    BMJ Open

  10. AASBO G, Solbraekke KN, Waller J, Trope A, et al
    Perspectives of non-attenders for cervical cancer screening in Norway: a qualitative focus group study.
    BMJ Open. 2019;9:e029505.
    PubMed     Text format     Abstract available

  11. NESSLER K, Chan SKF, Ball F, Storman M, et al
    Impact of family physicians on cervical cancer screening: cross-sectional questionnaire-based survey in a region of southern Poland.
    BMJ Open. 2019;9:e031317.
    PubMed     Text format     Abstract available

  12. TCHOUNGA B, Boni SP, Koffi JJ, Horo AG, et al
    Cervical cancer screening uptake and correlates among HIV-infected women: a cross-sectional survey in Cote d'Ivoire, West Africa.
    BMJ Open. 2019;9:e029882.
    PubMed     Text format     Abstract available


    Cancer Imaging

  13. HONG CM, Park SH, Chong GO, Lee YH, et al
    Enhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma.
    Cancer Imaging. 2019;19:43.
    PubMed     Text format     Abstract available


    Cancer Res Treat

  14. KIM J, Kim BK, Jeon DS, Lee CH, et al
    Type-Specific Viral Load and Physical State of HPV Type 16, 18, and 58 as Diagnostic Biomarkers for High-Grade Squamous Intraepithelial Lesions or Cervical Cancer.
    Cancer Res Treat. 2019 Aug 28. pii: crt.2019.152. doi: 10.4143/crt.2019.
    PubMed     Text format     Abstract available


    Carbohydr Polym

  15. ZHAO M, Gu L, Li Y, Chen S, et al
    Chitooligosaccharides display anti-tumor effects against human cervical cancer cells via the apoptotic and autophagic pathways.
    Carbohydr Polym. 2019;224:115171.
    PubMed     Text format     Abstract available

  16. YAN C, Liang N, Li Q, Yan P, et al
    Biotin and arginine modified hydroxypropyl-beta-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel.
    Carbohydr Polym. 2019;216:129-139.
    PubMed     Text format     Abstract available


    Cell Death Dis

  17. SUN Q, Yang Z, Li P, Wang X, et al
    A novel miRNA identified in GRSF1 complex drives the metastasis via the PIK3R3/AKT/NF-kappaB and TIMP3/MMP9 pathways in cervical cancer cells.
    Cell Death Dis. 2019;10:636.
    PubMed     Text format     Abstract available


    Ceska Gynekol

  18. CHAO YS, McCormack S, Sehnal B, Slama J, et al
    The changes in FIGO staging for carcinoma of the cervix uteri.
    Ceska Gynekol. 2019;84:216-221.
    PubMed     Text format     Abstract available


    Cytopathology

  19. PLACIDI A, Giorgi Rossi P
    The impact of blind peer review (team reading) of equivocal/abnormal Papanicolaou smears on inter-reader agreement.
    Cytopathology. 2019;30:105-108.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  20. TAN S, Tao Z, Bian X, Zhao Y, et al
    Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2019;241:99-103.
    PubMed     Text format     Abstract available


    Eur Radiol

  21. GAO S, Du S, Lu Z, Xin J, et al
    Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer.
    Eur Radiol. 2019 Sep 6. pii: 10.1007/s00330-019-06428.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  22. WANG AH, Zhao JM, Du J, Pang QX, et al
    Long noncoding RNA LUCAT1 promotes cervical cancer cell proliferation and invasion by upregulating MTA1.
    Eur Rev Med Pharmacol Sci. 2019;23:6824-6829.
    PubMed     Text format     Abstract available


    Front Oncol

  23. LIN Y, Ouyang Y, Chen K, Lu Z, et al
    Clinical Outcomes of Volumetric Modulated Arc Therapy Following Intracavitary/Interstitial Brachytherapy in Cervical Cancer: A Single Institution Retrospective Experience.
    Front Oncol. 2019;9:760.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  24. BJURBERG M, Holmberg E, Borgfeldt C, Floter-Radestad A, et al
    Primary treatment patterns and survival of cervical cancer in Sweden: A population-based Swedish Gynecologic Cancer Group Study.
    Gynecol Oncol. 2019 Aug 30. pii: S0090-8258(19)31474.
    PubMed     Text format     Abstract available

  25. RADER JS, Pan A, Corbin B, Iden M, et al
    Identification and validation of a prognostic proteomic signature for cervical cancer.
    Gynecol Oncol. 2019 Aug 30. pii: S0090-8258(19)31473.
    PubMed     Text format     Abstract available

  26. HIRAO N, Iwata T, Tanaka K, Nishio H, et al
    Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
    Gynecol Oncol. 2019 Aug 30. pii: S0090-8258(19)31478.
    PubMed     Text format     Abstract available


    In Vivo

  27. MUKAI Y, Koike I, Matsunaga T, Yokota NR, et al
    Radiation Therapy for Uterine Cervical Cancer With Lung Metastases Including Oligometastases.
    In Vivo. 2019;33:1677-1684.
    PubMed     Text format     Abstract available

  28. KOBAYASHI K, Murakami N, Takahashi K, Inaba K, et al
    Local Radiotherapy or Chemotherapy for Oligo-recurrent Cervical Cancer in Patients With Prior Pelvic Irradiation.
    In Vivo. 2019;33:1659-1665.
    PubMed     Text format     Abstract available


    Infection

  29. FARES E, McCloskey CB, Gutierrez A, Princiotta M, et al
    Vaccine strain Listeria monocytogenes bacteremia occurring 31 months after immunization.
    Infection. 2019;47:489-492.
    PubMed     Text format     Abstract available


    Int J Cancer

  30. WOESTENBERG PJ, Bogaards JA, King AJ, Leussink S, et al
    Assessment of herd effects among women and heterosexual men after girls-only HPV16/18 vaccination in the Netherlands: A repeated cross-sectional study.
    Int J Cancer. 2019;144:2718-2727.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  31. BONI S, Tchounga B, Comoe K, Guie P, et al
    Assessment of the scale-up of cervical cancer screening in Abidjan stratified by HIV status.
    Int J Gynaecol Obstet. 2019 Sep 4. doi: 10.1002/ijgo.12959.
    PubMed     Text format     Abstract available


    Int J Gynecol Cancer

  32. CHO WK, Kim YI, Park W, Yang K, et al
    Para-aortic lymph node recurrence after curative radiotherapy for cervical cancer.
    Int J Gynecol Cancer. 2019;29:1116-1120.
    PubMed     Text format     Abstract available

  33. FOKOM DOMGUE J, Manjuh F, Nulah K, Welty T, et al
    Onsite training of clinicians on new techniques to improve cervical cancer prevention in sub-Saharan Africa.
    Int J Gynecol Cancer. 2019 Aug 30. pii: ijgc-2019-000772.
    PubMed     Text format    

  34. LIN AJ, Wright JD, Dehdashti F, Siegel BA, et al
    Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with (18)F-fluorodeoxyglucose-positron emission tomography in stage IB cervical cancer.
    Int J Gynecol Cancer. 2019 Aug 30. pii: ijgc-2019-000528.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  35. SURADEJ B, Sookkhee S, Panyakaew J, Mungkornasawakul P, et al
    Kaempferia parviflora Extract Inhibits STAT3 Activation and Interleukin-6 Production in HeLa Cervical Cancer Cells.
    Int J Mol Sci. 2019;20.
    PubMed     Text format     Abstract available


    J Clin Microbiol

  36. OSTRBENK A, Xu L, Arbyn M, Poljak M, et al
    Clinical and analytical evaluation of the Anyplex II HPV HR Detection assay within the VALGENT-3 framework.
    J Clin Microbiol. 2018 Sep 12. pii: JCM.01176-18. doi: 10.1128/JCM.01176.
    PubMed     Text format     Abstract available


    J Exp Clin Cancer Res

  37. PRANATHARTHI A, Thomas P, Udayashankar AH, Bhavani C, et al
    RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer.
    J Exp Clin Cancer Res. 2019;38:392.
    PubMed     Text format     Abstract available


    J Gene Med

  38. YANG J, Liang B, Hou S
    TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577.
    J Gene Med. 2019 Sep 4:e3125. doi: 10.1002/jgm.3125.
    PubMed     Text format     Abstract available


    J Glob Oncol

  39. GEORGE R, Prasoona TS, Kandasamy R, Mani T, et al
    Regular Low-Dose Oral Metronidazole Is Associated With Fewer Vesicovaginal and Rectovaginal Fistulae in Recurrent Cervical Cancer: Results From a 10-Year Retrospective Cohort.
    J Glob Oncol. 2019;5:1-10.
    PubMed     Text format     Abstract available


    J Mass Spectrom

  40. STARODUBTSEVA NL, Brzhozovskiy AG, Bugrova AE, Kononikhin AS, et al
    Label-free cervicovaginal fluid proteome profiling reflects the cervix neoplastic transformation.
    J Mass Spectrom. 2019;54:693-703.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol

  41. ASALI F, Abdel-Razeq R, Al-Thunaibat A, Okour A, et al
    Jordanian women's attitudes towards cervical cancer screening: has the pattern changed?
    J Obstet Gynaecol. 2019 Sep 3:1-5. doi: 10.1080/01443615.2019.1635097.
    PubMed     Text format     Abstract available


    J Womens Health (Larchmt)

  42. TATAR O, Wade K, McBride E, Thompson E, et al
    Are Health Care Professionals Prepared to Implement Human Papillomavirus Testing? A Review of Psychosocial Determinants of Human Papillomavirus Test Acceptability in Primary Cervical Cancer Screening.
    J Womens Health (Larchmt). 2019 Sep 3. doi: 10.1089/jwh.2019.7678.
    PubMed     Text format     Abstract available


    Medicines (Basel)

  43. OLUSOLA P, Ousley K, Ndetan H, Singh KP, et al
    Cervical Cancer Prevention in Racially Disparate Rural Populations.
    Medicines (Basel). 2019;6.
    PubMed     Text format     Abstract available


    Mol Genet Genomic Med

  44. HAN L, Husaiyin S, Ma C, Niyazi M, et al
    Association study between the polymorphisms of angiogenesis-related genes and cervical cancer susceptibility in Chinese Uygur population.
    Mol Genet Genomic Med. 2019 Sep 2:e899. doi: 10.1002.
    PubMed     Text format     Abstract available


    Niger J Clin Pract

  45. AZUOGU BN, Umeokonkwo CD, Azuogu VC, Onwe OE, et al
    Appraisal of willingness to vaccinate daughters with human papilloma virus vaccine and cervical cancer screening uptake among mothers of adolescent students in Abakaliki, Nigeria.
    Niger J Clin Pract. 2019;22:1286-1291.
    PubMed     Text format     Abstract available


    Oncol Rep

  46. LIU Z, Zhu W, Kong X, Chen X, et al
    Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer.
    Oncol Rep. 2019 Aug 27. doi: 10.3892/or.2019.7294.
    PubMed     Text format     Abstract available


    Pan Afr Med J

  47. DONATUS L, Nina FK, Sama DJ, Nkfusai CN, et al
    Assessing the uptake of cervical cancer screening among women aged 25-65 years in Kumbo West Health District, Cameroon.
    Pan Afr Med J. 2019;33:106.
    PubMed     Text format     Abstract available


    PLoS One

  48. CHEN CP, Kung PT, Wang YH, Tsai WC, et al
    Effect of time interval from diagnosis to treatment for cervical cancer on survival: A nationwide cohort study.
    PLoS One. 2019;14:e0221946.
    PubMed     Text format     Abstract available


    Sci Rep

  49. KUBITSCHKE H, Wolf B, Morawetz E, Horn LC, et al
    Roadmap to Local Tumour Growth: Insights from Cervical Cancer.
    Sci Rep. 2019;9:12768.
    PubMed     Text format     Abstract available


    Zhongguo Yi Xue Ke Xue Yuan Xue Bao

  50. ZHEN HN, Tian Y, Shen J, Ma JB, et al
    [Sexual Quality of Life in Patients with Cervical Cancer Undergoing Radiotherapy].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41:501-505.
    PubMed     Text format     Abstract available


    Zhonghua Fu Chan Ke Za Zhi

  51. CHEN LM, Liu L, Tao X, He Y, et al
    [Analysis of recurrence and its influencing factors in patients with cervical HSIL within 24 months after LEEP].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:534-540.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: